Evidence map›Paper›PMID 33903133›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.

Leora Branfield Day, Husam Abdel-Qadir, Michael Fralick

Abstract readCase Reports
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Remdesivir in COVID-19: A Focus on Pediatric Cardiac Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Remdesivir-Induced Bradycardia.Southern medical journal · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Safety profile of COVID-19 drugs in a real clinical setting.European journal of clinical pharmacology · 2022
    Review
  16. Article
  17. Complete AV Block in Vaccinated COVID-19 Patient.Case reports in cardiology · 2022
    Article
  18. Remdesivir-associated bradycardia.BMJ case reports · 2021
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leora Branfield DayDivision of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont.
Husam Abdel-QadirDivision of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont.
Michael FralickDivision of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont. mike.fralick@mail.utoronto.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentAdenosine MonophosphateAlanineAntiviral AgentsBradycardiaHumansMaleMiddle AgedAdenosine MonophosphateAlanineAntiviral Agentsremdesivir

Identifiers

PMID33903133
PMCPMC8101980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.